Copyright
©The Author(s) 2015.
World J Biol Chem. Nov 26, 2015; 6(4): 333-345
Published online Nov 26, 2015. doi: 10.4331/wjbc.v6.i4.333
Published online Nov 26, 2015. doi: 10.4331/wjbc.v6.i4.333
Histone PTM | Writer | Eraser | Function | Cancer Diagnosis/ Prognosis/ Treatment |
H3K9ac | GCN-5 | SIRT-1; SIRT-6 | Transcription initiation | Diagnosis: ? |
Prognosis: Lung, breast, ovarian | ||||
Treatment: ? | ||||
H3K18ac | CBP/p300 | ? | Transcription initiation and repression | Diagnosis: ? |
Prognosis: Lung, prostate, breast, esophagus | ||||
Treatment: ? | ||||
H4K5ac | CBP/P300; HAT1; TIP60; HB01 | ? | Transcription activation | Diagnosis: ? |
Prognosis: Lung | ||||
Treatment: ? | ||||
H4K8ac | TIP60; HB01 | ? | Transcription activation | Diagnosis: ? |
Prognosis: Lung, | ||||
Treatment: ? | ||||
H4K16ac | TIP60; hMOF | SIRT-1; SIRT-2 | Transcription activation | Diagnosis: Colorectal |
Prognosis: Lung, breast | ||||
Treatment: ? | ||||
H3K4me | SETD1A; SETD1B; ASH1L; MLL; MLL2; MLL3: MLL4; SETD7 | KDM1A; KDM1B; KDM5B; NO66 | Transcription activation | Diagnosis: ? |
Prognosis: Prostate, kidney | ||||
Treatment: ? | ||||
H3K4me2 | SETD1A; SETD1B; MLL; MLL2; MLL3; MLL4; SMYD3 | KDM1A; KDM1B; KDM5A; KDM5B; KDM5C; KDM5D; NO66 | Transcription activation | Diagnosis: ? |
Prognosis: Prostate, lung, kidney, breast, pancreatic, liver, | ||||
Treatment: ? | ||||
H3K4me3 | SETD1A; SETD1B; ASH1L; MLL; MLL2; MLL3; MLL4; SMYD3; PRMD9 | KDM2B; KDM5A; KDM5B; KDM5C; KDM5D; NO66 | Transcription elongation | Diagnosis: ? |
Prognosis: Kidney, liver, prostate | ||||
Treatment: ? | ||||
H3K9me | SETDB1; G9a; EHMT1; PRDM2 | KDM3A; KDM3B§; PHF8; JHDM1D | Transcription initiation | Diagnosis: Myeloma |
Prognosis: Kidney, pancreas, prostate | ||||
Treatment: ? | ||||
H3K9me2 | SUV39H1; SUV39H2; SETDB1; G9a; EHMT1; PRDM2 | KDM3A; KDM3B§; KDM4A; KDM4B; KDM4C; KDM4D; PHF8; KDM1A; JHDM1D | Transcription initiation and repression | Diagnosis: ? |
Prognosis: Prostate, pancreas | ||||
Treatment: ? | ||||
H3K9me3 | SUV39H1; SUV39H2; SETDB1; PRDM2 | KDM3B§; KDM4A; KDM4B; KDM4C; KDM4D | Transcription initiation and repression | Diagnosis: Colorectal, myeloma, prostate, breast and lung |
Prognosis: Lung, prostate, breast, leukemia, stomach | ||||
Treatment: ? | ||||
H3K27me | EZH2; EZH1 | JHDM1D | Transcription activation | Diagnosis: ? |
Prognosis: Kidney | ||||
Treatment: ? | ||||
H3K27me3 | EZH2; EZH1 | KDM6A; KDM6B; | Transcription repression | Diagnosis: ? |
Prognosis: Breast, pancreatic, ovarian, prostate, stomach, Esophagus, Liver | ||||
Treatment: ? | ||||
H4K20me3 | SUV420H1; SUV420H2 | ? | Transcription repression | Diagnosis: Colorectal, myeloma, prostate, breast and lung |
Prognosis: Breast, lymphoma, colon, ovarian | ||||
Treatment: ? |
- Citation: Khan SA, Reddy D, Gupta S. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem 2015; 6(4): 333-345
- URL: https://www.wjgnet.com/1949-8454/full/v6/i4/333.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v6.i4.333